Tolerability and safety of escalating rifapentine (RPT) doses during the first 2 months of tuberculosis (TB) treatment

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2013
This article has no abstract
Epistemonikos ID: b63ac1ca91fe5215b1fd568de8b9a5905dd92d1a
First added on: Feb 07, 2025